International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 556-563 doi: 10.5281/zenodo.16867973
Original Article
Optical Coherence Tomography Angiography Biomarkers Changes After Cataract Surgery on Macula in Diabetic Retinopathy with No Diabetic Macular Edema: An Interventional Study
 ,
 ,
 ,
Published
Aug. 13, 2025
Abstract

Background: Diabetic retinopathy (DR) patients undergoing cataract surgery face potential microvascular complications, but the precise impact on macular perfusion remains unclear. This study aimed to evaluate postoperative changes in retinal microvasculature using optical coherence tomography angiography (OCTA) in DR patients without diabetic macular edema (DME) compared to non-diabetic controls.

Methods: A prospective interventional study was conducted on 108 eyes (54 DR patients and 54 controls) undergoing phacoemulsification. OCTA parameters—macular thickness (MT), superficial capillary plexus vessel density (SCP VD), perfusion density (SCP PD), and foveal avascular zone (FAZ) area—were analyzed preoperatively and 3 months postoperatively. Statistical comparisons employed paired and independent t-tests (*p* < 0.05 significant).

Results: MT increased significantly in both groups postoperatively (*p* < 0.001), with no intergroup difference in magnitude. SCP VD and SCP PD rose significantly in DR patients (*p* < 0.001) but remained unchanged in controls. FAZ area expanded in DR patients (*p* < 0.001), while controls showed no significant change.

Conclusion: Cataract surgery induces distinct microvascular remodeling in DR patients, characterized by increased SCP perfusion and FAZ enlargement, which may signal subclinical DR progression. OCTA demonstrates utility in detecting these early changes, advocating for tailored postoperative surveillance in diabetic populations to preempt vision-threatening complications.

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
869 Views
285 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved